May 5, 2015: Risk and Funds Flow in the Health Care Marketplace

UW Bioengineering welcomes Joseph M. Gifford, M.D., Chief Executive, Providence ACO, to the Health Innovators Collaborative Seminar Series. Talk title: Risk and Funds Flow in the Health Care Marketplace.

March 3, 2015: Delivering Innovation Across the Health Care Continuum

UW Bioengineering welcomes Christopher Hall of Philips Healthcare to its Health Innovators Collaborative seminar series
Talk title: Delivering Innovation Across the Health Care Continuum

March 30, 2015: Providing Better Care with Less

UW Bioengineering welcomes Arnold Milstein of Harvard University and the Pacific Business Group on Health to its Health Innovators Collaborative Seminar. Talk title: Providing Better Care with Less

February 3, 2015: Entering the Era of Consumer-Driven Access and Delivery

UW Bioengineering welcomes Ralph C. Derrickson, President and CEO, Carena, Inc., to its Health Innovators Collaborative seminar series. Talk title: Entering the Era of Consumer-Driven Access and Delivery.

January 6, 2015: A Novel Regional Approach to Address the Crisis in Quality and Cost in Cancer

UW Bioengineering welcomes Scott Ramsey of Fred Hutchinson Cancer Research Center to its January 2015 Health Innovators Collaborative lecture.

December 2, 2014: The Boeing ACO: Potential Model for Next Generation Healthcare

UW Bioengineering welcomes Greg Marchand, Director of Benefits Policy and Strategy, The Boeing Company, to its Health Innovators Collaborative seminar series

November 4, 2014: Building a new epicenter for healthcare innovation – Cambia’s bet on the Pacific Northwest

Rob Coppedge, Senior Vice President Strategic Investment and Corporate Development, Cambia Health Solutions will discuss how Cambia Health Solutions, a company with a long history in the region, is making a big investment in Seattle’s health care innovation infrastructure.

April 1, 2014: Seismic Changes of Healthcare Necessitate New Approaches to Innovation: A National Perspective

Oren Lang-Furr, a Partner at Ernst & Young serving EY’s life sciences clients, will draw on his firm’s extensive evaluation of the new realities emerging in medtech, biotech and pharma and the major adjustments innovators need to make.

April 22, 2014: “The Transformation of Healthcare: Forces, Directions and Implications”

Paul Ramsey, MD, CEO of UW Medicine, will discuss the shift of healthcare toward Accountable Care Organizations, the dramatic changes of financial incentives and the consequent implications for innovations.

May 13, 2014: “Demonstrating Value in Health Innovation: Lessons from Comparative Effectiveness Research”

Larry Kessler, ScD, Chair of UW Deptment of Health Services and former Director, Center for Devices and Radiological Health, FDA, will consider the coming necessity for innovations to demonstrably provide value and how the experience with comparative effectiveness can help innovators gather the needed evidence.